EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark GAMIFANT was filed as Word mark on 12/28/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/01/2017.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 016212441 |
| Application date | December 28, 2016 |
| Publication date | January 20, 2017 |
| Entry date | May 1, 2017 |
| Expiration date | December 28, 2026 |
Trademark owner
12 ch. des Aulx
1228 Plan-les-Ouates, Geneva
CH
1228 Plan-les-Ouates, Geneva
CH
Trademark representatives
Bischoffsheimlaan 15
1000 Brussels
BE
goods and services
1
Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes
5
Pharmaceutical and biological preparations; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies; immunotherapies, pharmaceutical and biological preparations for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemicals, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 26, 2022 | Transfer / Change of address, Published | ||
| March 24, 2022 | Transfer / Change of address, Published | ||
| January 7, 2021 | Change Representative, Published | ||
| January 5, 2021 | Change Representative, Published | ||
| January 13, 2017 | Transfer / Change of address, Registered |
ID: 11016212441